Ocugen earnings estimates raised as Oculis board member resigns

Analysts at HC Wainwright have raised their FY2026 earnings estimates for Ocugen, Inc. The firm now expects the company to post earnings of ($0.27) per share, an improvement from the previous forecast of ($0.28).

Separately, Oculis Holding AG announced that Lionel Carnot is resigning from its Board of Directors, effective September 30, 2026. Carnot has served on the board since 2017, overseeing the company’s transition from a private startup to a publicly listed biopharmaceutical firm. The company stated his departure is a personal decision and not due to disagreements regarding operations or policies. Following the resignation, the board will consist of eight members, with Geraldine O’Keeffe taking over as chair of the Remuneration Committee.